BIB241220P75000
- 0.00
- 0.000.00%
Ultra Nasdaq Biotechnology Proshares Newsroom
AstraZeneca Reports Positive Phase 3 Results for Truqap in Prostate Cancer
Vertex Leads J.P. Morgan's Top Biotech Picks List for 2025
Gilead Acquires Investigational HIV Vaccine From Spanish Biotech Aelix
Looking Into Vertex Pharmaceuticals's Recent Short Interest
Price Over Earnings Overview: Gilead Sciences
Pfizer Meets Amyloidosis Rival as BridgeBio Wins FDA Nod for Attruby
Trump Picks Surgeon Makary to Head FDA, Rep. Dave Weldon to Lead CDC
Catalyst Watch: Robotaxi IPO, OPEC+, Holiday Shopping Data, and Movie Blockbusters
3 'Buy' Stocks and 2 'Hold' Stocks According to Oppenheimer
Viking Therapeutics a New Buy at B Riley on Lead Obesity Asset VK2735
Amneal Gets FDA Approval for Generic Byetta, Resubmits DHE NDA
Optimism Over Global Healthcare Sector Rises: Jefferies
AstraZeneca's Andexxa Faces FDA Scrutiny Over Effectiveness, Safety Concerns
Gilead Sciences Analyst Ratings
Biogen Analyst Ratings
Following the US Secretary of Health, Trump's nomination for the FDA Commissioner seems to be another anti-vaccine advocate.
Makari is a surgeon who opposes overtreatment, advocates for re-evaluating hormone replacement therapy, and reducing the overuse of antibiotics.
CDC Warns Against a Spike in COVID, Flu Cases
Decoding Amgen's Options Activity: What's the Big Picture?
Biogen Gains Momentum With Positive Lupus Drug Results, Analyst Sees Modest Valuation Upside
U.S. CDC Says Flu, Covid-19, RSV Illnesses Are At Low Levels Right Now Overall In U.S., But We Expect Them To Increase In Coming Weeks; Expects Hospitalizations For Flu And Covid-19 To Start Increasing In Coming Weeks